TAA 27. Early Results of One-Stage Repair for Aortic and Coronary Artery Disease

The objective of this study was to analyze information from a single clinical center evaluating early results of one-stage endovascular repair for aortic disease and coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) for coronary artery disease. From January 2018 to March 2019, five patients (three men, two women; age range, 53-69 years) with concomitant aortic disease (aortic dissection, abdominal aortic aneurysm) and coronary artery disease were treated with one-stage thoracic endovascular aortic repair (TEVAR) or endovascular aneurysm repair (EVAR) and CABG or PCI. All patients had significant comorbidities. The follow-up rate was 100% during a period of 3 to 12 months. Technical success was achieved in all patients, including PCI with TEVAR in two patients, PCI with EVAR in two patients, and CABG (three branches) with EVAR in one patient. The average procedure time was 244 minutes (range, 200-360 minutes). Mean contrast agent volume was 100 mL (range, 70-180 mL). The average in-hospital time was 8.2 days (range, 7-12 days). None of the patients developed myocardial infarction or aortic rupture. TEVAR or EVAR combining CABG or PCI as a one-stage procedure can be performed successfully with less operative time and risk, considering the complexity of both operations.